Quest has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has ...

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Feb. 19, 2025 /PRNewswire/ -- USA News Group News Commentary - Amid the excitement surrounding ...

Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.

Drug Screening Market Report Information By Product and Service (Drug Screening, Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Service), By Sample Typ ...

NEW YORK – Drawing on its longstanding partnership with Becton Dickinson, Babson Diagnostics is aiming to further expand use of its US Food and Drug Administration-cleared blood collection system ...

Grail (GRAL) stock shot up 33% Thursday, the day after the company announced a partnership with Quest (DGX) to expand provider access to Grail's Galleri multi-cancer early detection test.

Labcorp Holdings Inc. leverages strategic moves like the Fortrea spin-off and Invitae acquisition to drive growth. Read more ...

Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare ...

GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, and Quest Diagnostics , a leading provider of diagnostic information services, today announced the ...

More than one year after Cleveland Diagnostics closed on $75 million in growth capital, the biotech company is scaling up ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions ...